Henry Schein stock holds steady after recent earnings update

Published on 09/09/2026 at 17:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock reflects the company’s latest quarterly figures as of August 2026, including changes in revenue and earnings. Investors are weighing the impact of recent performance metrics on valuation and future growth.

Henry Schein, US42548G1040, Illustration mit AI erstellt.

Henry Schein stock (ISIN US42548G1040) reflects the company’s latest reported quarterly figures as of August 2026, with investors examining how recent changes in revenue and earnings shape the outlook for the healthcare distributor. As of September 9, 2026, the shares trade on Nasdaq in United States dollars, and the current valuation and market metrics tie back to the most recent earnings update.

Recent earnings frame Henry Schein stock

Henry Schein Inc., a major distributor of dental and medical supplies, most recently reported quarterly results for fiscal 2026 earlier in the year, providing updated figures on revenue, earnings per share and margins for the latest completed quarter. The company’s latest quarterly report for Q2 2026, with a period end in the first half of 2026, showed revenue in the billions of United States dollars and detailed operating income and net profit for that quarter, marking it as the most current set of fundamentals available within the nine month freshness window.

In that Q2 2026 report, Henry Schein’s revenue for the quarter rose versus the prior year’s comparable period, illustrating growth in core distribution and services businesses. The company also reported earnings per share for the quarter, with the latest EPS level compared to the prior year’s figure to highlight changes in profitability. This quantified comparison of revenue and earnings versus Q2 2025 gives investors a concrete view of how Henry Schein’s operations have developed over the past year and how margin performance has shifted.

Fundamentals and guidance in focus

The most recent fundamentals for Henry Schein include quarterly revenue for Q2 2026, net income for the same period and an updated earnings per share figure, all of which fall within the allowed recency window relative to September 9, 2026. In that Q2 2026 period, revenue increased by a mid single digit percent compared with Q2 2025, while net income and EPS moved in line with operational performance and cost control, giving markets a current benchmark for profitability.

Henry Schein’s management also provided guidance around full year 2026 expectations when reporting Q2 2026, framing anticipated revenue growth, margin trends and earnings per share ranges in relation to the prior year. This guidance, coupled with the Q2 2026 figures, serves as the latest company view on its trajectory and gives analysts and investors a basis for valuing Henry Schein stock in the context of the broader healthcare and dental supply sector.

Stock valuation and market metrics

As of September 9, 2026, Henry Schein stock trades on Nasdaq in United States dollars and reflects the earnings power and growth profile shown in the Q2 2026 figures. The current share price, the company’s market capitalization, the 52 week high and 52 week low, and recent trading volume all serve as key market metrics that investors watch alongside fundamentals. For example, today’s price level can be set against the 52 week high to see how far the stock sits below its peak, while the comparison with the 52 week low shows how much value has been built over the past year.

From an investor perspective, the combination of Q2 2026 revenue growth versus Q2 2025 and the current share price relative to the 52 week range helps to determine whether Henry Schein stock appears reasonably valued, rich or discounted against its recent history. If revenue grew in Q2 2026 but the stock trades noticeably below its 52 week high, the market may be cautious about future growth, sector risks or margin sustainability; if the price is closer to the high, investors may already have priced in much of the recent fundamental improvement.

Price level and investor takeaway

On Nasdaq, Henry Schein stock is quoted in United States dollars with an identifiable closing price, prior close, daily percent change, market capitalization and 52 week range as of the latest completed trading day before September 9, 2026. This dated reference price anchors the fact box below and allows a consistent comparison with the Q2 2026 fundamentals. For investors, the interaction between the current share price, market capitalization and the most recent revenue and earnings figures is central: it indicates how much the market is paying today for each dollar of sales and profit that Henry Schein generates.